Mostrar el registro sencillo del ítem
dc.contributor.author | Vivas Consuelo, David José Juan | es_ES |
dc.contributor.author | Usó Talamantes, Ruth | es_ES |
dc.contributor.author | Trillo Mata, José Luis | es_ES |
dc.contributor.author | Mendez Valera, Pablo | es_ES |
dc.date.accessioned | 2016-05-20T13:06:14Z | |
dc.date.available | 2016-05-20T13:06:14Z | |
dc.date.issued | 2015-06 | |
dc.identifier.issn | 1473-7167 | |
dc.identifier.uri | http://hdl.handle.net/10251/64486 | |
dc.description.abstract | Multimorbidity is the main cause of polypharmacy in elderly people, with the consequent increment in cost and use of inappropriate medication. To control cost, specific strategies have been implemented in healthcare services to reduce potentially inappropriate prescription. Many interventions are applied online during the prescription process using computerized decision support systems, for example, therapeutic algorithms and alerts. Other interventions can be categorized as offline due to their application before or after the prescription process, the main strategies being financial incentives, medication reviews and organizational change. All these strategies are complementary and multifaceted. There is evidence that some of these interventions are effective, but further research should be directed in this field, including investigation of patient cost and outcomes. | es_ES |
dc.language | Inglés | es_ES |
dc.publisher | Expert Reviews (formerly Future Drugs) | es_ES |
dc.relation.ispartof | Expert Review of Pharmacoeconomics and Outcomes Research | es_ES |
dc.rights | Reserva de todos los derechos | es_ES |
dc.subject | Computerized support systems | es_ES |
dc.subject | Cost control | es_ES |
dc.subject | Inappropriate prescribing | es_ES |
dc.subject | Medication-related problems | es_ES |
dc.subject | Multimorbidity | es_ES |
dc.subject | Older people | es_ES |
dc.subject | Polypharmacy | es_ES |
dc.subject | Risk adjustment | es_ES |
dc.subject.classification | ECONOMIA APLICADA | es_ES |
dc.title | Methods to control the pharmaceutical cost impact of chronic conditions in the elderly | es_ES |
dc.type | Artículo | es_ES |
dc.identifier.doi | 10.1586/14737167.2015.1017564 | |
dc.rights.accessRights | Cerrado | es_ES |
dc.contributor.affiliation | Universitat Politècnica de València. Departamento de Economía y Ciencias Sociales - Departament d'Economia i Ciències Socials | es_ES |
dc.description.bibliographicCitation | Vivas Consuelo, DJJ.; Usó Talamantes, R.; Trillo Mata, JL.; Mendez Valera, P. (2015). Methods to control the pharmaceutical cost impact of chronic conditions in the elderly. Expert Review of Pharmacoeconomics and Outcomes Research. 15(3):425-427. doi:10.1586/14737167.2015.1017564 | es_ES |
dc.description.accrualMethod | S | es_ES |
dc.relation.publisherversion | http://dx.doi.org/10.1586/14737167.2015.1017564 | es_ES |
dc.description.upvformatpinicio | 425 | es_ES |
dc.description.upvformatpfin | 427 | es_ES |
dc.type.version | info:eu-repo/semantics/publishedVersion | es_ES |
dc.description.volume | 15 | es_ES |
dc.description.issue | 3 | es_ES |
dc.relation.senia | 281873 | es_ES |
dc.identifier.eissn | 1744-8379 | |
dc.description.references | Spinewine, A., Schmader, K. E., Barber, N., Hughes, C., Lapane, K. L., Swine, C., & Hanlon, J. T. (2007). Appropriate prescribing in elderly people: how well can it be measured and optimised? The Lancet, 370(9582), 173-184. doi:10.1016/s0140-6736(07)61091-5 | es_ES |
dc.description.references | Wagner, E. H. (2001). Meeting the needs of chronically ill people. BMJ, 323(7319), 945-946. doi:10.1136/bmj.323.7319.945 | es_ES |
dc.description.references | Hoffman, C. (1996). Persons with chronic conditions. Their prevalence and costs. JAMA: The Journal of the American Medical Association, 276(18), 1473-1479. doi:10.1001/jama.276.18.1473 | es_ES |
dc.description.references | Lehnert, T., Heider, D., Leicht, H., Heinrich, S., Corrieri, S., Luppa, M., … König, H.-H. (2011). Review: Health Care Utilization and Costs of Elderly Persons With Multiple Chronic Conditions. Medical Care Research and Review, 68(4), 387-420. doi:10.1177/1077558711399580 | es_ES |
dc.description.references | Mueller, C., Schur, C., & O’Connell, J. (1997). Prescription drug spending: the impact of age and chronic disease status. American Journal of Public Health, 87(10), 1626-1629. doi:10.2105/ajph.87.10.1626 | es_ES |
dc.description.references | Sambamoorthi, U., Shea, D., & Crystal, S. (2003). Total and Out-of-Pocket Expenditures for Prescription Drugs Among Older Persons. The Gerontologist, 43(3), 345-359. doi:10.1093/geront/43.3.345 | es_ES |
dc.description.references | Rogowski, J., Lillard, L. A., & Kington, R. (1997). The Financial Burden of Prescription Drug Use Among Elderly Persons. The Gerontologist, 37(4), 475-482. doi:10.1093/geront/37.4.475 | es_ES |
dc.description.references | Fahlman, C., Lynn, J., Doberman, D., Gabel, J., & Finch, M. (2006). Prescription Drug Spending for Medicare+Choice Beneficiaries in the Last Year of Life. Journal of Palliative Medicine, 9(4), 884-893. doi:10.1089/jpm.2006.9.884 | es_ES |
dc.description.references | Vivas, D., Guadalajara, N., Barrachina, I., Trillo, J.-L., Usó, R., & de-la-Poza, E. (2011). Explaining primary healthcare pharmacy expenditure using classification of medications for chronic conditions. Health Policy, 103(1), 9-15. doi:10.1016/j.healthpol.2011.08.014 | es_ES |
dc.description.references | Kaufman, D. W., Kelly, J. P., Rosenberg, L., Anderson, T. E., & Mitchell, A. A. (2002). Recent Patterns of Medication Use in the Ambulatory Adult Population of the United States. JAMA, 287(3), 337. doi:10.1001/jama.287.3.337 | es_ES |
dc.description.references | Fortin, M., Stewart, M., Poitras, M.-E., Almirall, J., & Maddocks, H. (2012). A Systematic Review of Prevalence Studies on Multimorbidity: Toward a More Uniform Methodology. The Annals of Family Medicine, 10(2), 142-151. doi:10.1370/afm.1337 | es_ES |
dc.description.references | Rollason, V., & Vogt, N. (2003). Reduction of Polypharmacy in the Elderly. Drugs & Aging, 20(11), 817-832. doi:10.2165/00002512-200320110-00003 | es_ES |
dc.description.references | Bradley, M. C., Fahey, T., Cahir, C., Bennett, K., O’Reilly, D., Parsons, C., & Hughes, C. M. (2012). Potentially inappropriate prescribing and cost outcomes for older people: a cross-sectional study using the Northern Ireland Enhanced Prescribing Database. European Journal of Clinical Pharmacology, 68(10), 1425-1433. doi:10.1007/s00228-012-1249-y | es_ES |
dc.description.references | Vivas-Consuelo, D., Usó-Talamantes, R., Trillo-Mata, J. L., Caballer-Tarazona, M., Barrachina-Martínez, I., & Buigues-Pastor, L. (2014). Predictability of pharmaceutical spending in primary health services using Clinical Risk Groups. Health Policy, 116(2-3), 188-195. doi:10.1016/j.healthpol.2014.01.012 | es_ES |
dc.description.references | Feinstein, A. R. (1970). The pre-therapeutic classification of co-morbidity in chronic disease. Journal of Chronic Diseases, 23(7), 455-468. doi:10.1016/0021-9681(70)90054-8 | es_ES |
dc.description.references | Van den Akker, M., Buntinx, F., Metsemakers, J. F. M., Roos, S., & Knottnerus, J. A. (1998). Multimorbidity in General Practice: Prevalence, Incidence, and Determinants of Co-Occurring Chronic and Recurrent Diseases. Journal of Clinical Epidemiology, 51(5), 367-375. doi:10.1016/s0895-4356(97)00306-5 | es_ES |
dc.description.references | Bayliss, E. A., Ellis, J. L., & Steiner, J. F. (2005). Health and Quality of Life Outcomes, 3(1), 51. doi:10.1186/1477-7525-3-51 | es_ES |
dc.description.references | Valderas, J. M., Starfield, B., Sibbald, B., Salisbury, C., & Roland, M. (2009). Defining Comorbidity: Implications for Understanding Health and Health Services. The Annals of Family Medicine, 7(4), 357-363. doi:10.1370/afm.983 | es_ES |
dc.description.references | Starfield, B. (2006). Threads and Yarns: Weaving the Tapestry of Comorbidity. The Annals of Family Medicine, 4(2), 101-103. doi:10.1370/afm.524 | es_ES |
dc.description.references | Diederichs, C., Berger, K., & Bartels, D. B. (2010). The Measurement of Multiple Chronic Diseases--A Systematic Review on Existing Multimorbidity Indices. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 66A(3), 301-311. doi:10.1093/gerona/glq208 | es_ES |
dc.description.references | Smith, S. M., Soubhi, H., Fortin, M., Hudon, C., & O’Dowd, T. (2012). Managing patients with multimorbidity: systematic review of interventions in primary care and community settings. BMJ, 345(sep03 1), e5205-e5205. doi:10.1136/bmj.e5205 | es_ES |
dc.description.references | Prados-Torres, A., Calderón-Larrañaga, A., Hancco-Saavedra, J., Poblador-Plou, B., & van den Akker, M. (2014). Multimorbidity patterns: a systematic review. Journal of Clinical Epidemiology, 67(3), 254-266. doi:10.1016/j.jclinepi.2013.09.021 | es_ES |
dc.description.references | Bower, P., Harkness, E., Macdonald, W., Coventry, P., Bundy, C., & Moss-Morris, R. (2012). Illness representations in patients with multimorbid long-term conditions: Qualitative study. Psychology & Health, 27(10), 1211-1226. doi:10.1080/08870446.2012.662973 | es_ES |
dc.description.references | Sundararajan, V., Henderson, T., Perry, C., Muggivan, A., Quan, H., & Ghali, W. A. (2004). New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality. Journal of Clinical Epidemiology, 57(12), 1288-1294. doi:10.1016/j.jclinepi.2004.03.012 | es_ES |
dc.description.references | Glynn, L. G., Valderas, J. M., Healy, P., Burke, E., Newell, J., Gillespie, P., & Murphy, A. W. (2011). The prevalence of multimorbidity in primary care and its effect on health care utilization and cost. Family Practice, 28(5), 516-523. doi:10.1093/fampra/cmr013 | es_ES |
dc.description.references | Barnett, K., Mercer, S. W., Norbury, M., Watt, G., Wyke, S., & Guthrie, B. (2012). Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. The Lancet, 380(9836), 37-43. doi:10.1016/s0140-6736(12)60240-2 | es_ES |
dc.description.references | Holden, L., Scuffham, P. A., Hilton, M. F., Muspratt, A., Ng, S.-K., & Whiteford, H. A. (2011). Patterns of multimorbidity in working Australians. Population Health Metrics, 9(1). doi:10.1186/1478-7954-9-15 | es_ES |
dc.description.references | Fortin, M., Lapointe, L., Hudon, C., Vanasse, A., Ntetu, A. L., & Maltais, D. (2004). Health and Quality of Life Outcomes, 2(1), 51. doi:10.1186/1477-7525-2-51 | es_ES |
dc.description.references | Schellevis, F. G., van der Velden, J., van de Lisdonk, E., van Eijk, J. T. M., & van Weel, C. (1993). Comorbidity of chronic diseases in general practice. Journal of Clinical Epidemiology, 46(5), 469-473. doi:10.1016/0895-4356(93)90024-u | es_ES |
dc.description.references | Schäfer, I., Hansen, H., Schön, G., Maier, W., Höfels, S., Altiner, A., … van den Bussche, H. (2009). The German MultiCare-study: Patterns of multimorbidity in primary health care – protocol of a prospective cohort study. BMC Health Services Research, 9(1). doi:10.1186/1472-6963-9-145 | es_ES |
dc.description.references | Schäfer, I., von Leitner, E.-C., Schön, G., Koller, D., Hansen, H., Kolonko, T., … van den Bussche, H. (2010). Multimorbidity Patterns in the Elderly: A New Approach of Disease Clustering Identifies Complex Interrelations between Chronic Conditions. PLoS ONE, 5(12), e15941. doi:10.1371/journal.pone.0015941 | es_ES |
dc.description.references | Van den Bussche, H., Koller, D., Kolonko, T., Hansen, H., Wegscheider, K., Glaeske, G., … Schön, G. (2011). Which chronic diseases and disease combinations are specific to multimorbidity in the elderly? Results of a claims data based cross-sectional study in Germany. BMC Public Health, 11(1). doi:10.1186/1471-2458-11-101 | es_ES |
dc.description.references | König, H.-H., Leicht, H., Bickel, H., Fuchs, A., Gensichen, J., … Eckardt, M. (2013). Effects of multiple chronic conditions on health care costs: an analysis based on an advanced tree-based regression model. BMC Health Services Research, 13(1). doi:10.1186/1472-6963-13-219 | es_ES |
dc.description.references | Teljeur, C., Smith, S. M., Paul, G., Kelly, A., & O’Dowd, T. (2013). Multimorbidity in a cohort of patients with type 2 diabetes. European Journal of General Practice, 19(1), 17-22. doi:10.3109/13814788.2012.714768 | es_ES |
dc.description.references | Poblador-Plou, B., van den Akker, M., Vos, R., Calderón-Larrañaga, A., Metsemakers, J., & Prados-Torres, A. (2014). Similar Multimorbidity Patterns in Primary Care Patients from Two European Regions: Results of a Factor Analysis. PLoS ONE, 9(6), e100375. doi:10.1371/journal.pone.0100375 | es_ES |
dc.description.references | Fulton, M. M., & Riley Allen, E. (2005). Polypharmacy in the elderly: A literature review. Journal of the American Academy of Nurse Practitioners, 17(4), 123-132. doi:10.1111/j.1041-2972.2005.0020.x | es_ES |
dc.description.references | Boudreau, D. M., Yu, O., Gray, S. L., Raebel, M. A., Johnson, J., & Larson, E. B. (2011). Concomitant Use of Cholinesterase Inhibitors and Anticholinergics: Prevalence and Outcomes. Journal of the American Geriatrics Society, 59(11), 2069-2076. doi:10.1111/j.1532-5415.2011.03654.x | es_ES |
dc.description.references | Veehof, L., Stewart, R., Haaijer-Ruskamp, F., & Jong, B. M. -d. (2000). The development of polypharmacy. A longitudinal study. Family Practice, 17(3), 261-267. doi:10.1093/fampra/17.3.261 | es_ES |
dc.description.references | Fialová, D. (2005). Potentially Inappropriate Medication Use Among Elderly Home Care Patients in Europe. JAMA, 293(11), 1348. doi:10.1001/jama.293.11.1348 | es_ES |
dc.description.references | Bjerrum, L., Rosholm, J. U., Hallas, J., & Kragstrup, J. (1997). Methods for estimating the occurrence of polypharmacy by means of a prescription database. European Journal of Clinical Pharmacology, 53(1), 7-11. doi:10.1007/s002280050329 | es_ES |
dc.description.references | Moen, J., Antonov, K., Larsson, C. A., Lindblad, U., Nilsson, J. L. G., Råstam, L., & Ring, L. (2009). Factors Associated with Multiple Medication Use in Different Age Groups. Annals of Pharmacotherapy, 43(12), 1978-1985. doi:10.1345/aph.1m354 | es_ES |
dc.description.references | Orueta Sánchez, R., Santos Rodríguez, C., González Hidalgo, E., Fagundo Becerra, E. M., Alejandre Lázaro, G., Carmona de la Morena, J., … Butrón Gómez, T. (2011). Medicalización de la vida (I). Revista Clínica de Medicina de Familia, 4(2). doi:10.4321/s1699-695x2011000200011 | es_ES |
dc.description.references | Onder, G., Petrovic, M., Tangiisuran, B., Meinardi, M. C., Markito-Notenboom, W. P., Somers, A., … van der Cammen, T. J. M. (2010). Development and Validation of a Score to Assess Risk of Adverse Drug Reactions Among In-Hospital Patients 65 Years or Older. Archives of Internal Medicine, 170(13). doi:10.1001/archinternmed.2010.153 | es_ES |
dc.description.references | Onder, G., Liperoti, R., Fialova, D., Topinkova, E., Tosato, M., … Danese, P. (2012). Polypharmacy in Nursing Home in Europe: Results From the SHELTER Study. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 67A(6), 698-704. doi:10.1093/gerona/glr233 | es_ES |
dc.description.references | Hanlon, J. T., Schmader, K. E., Koronkowski, M. J., Weinberger, M., Landsman, P. B., Samsa, G. P., & Lewis, I. K. (1997). Adverse Drug Events In High Risk Older Outpatients. Journal of the American Geriatrics Society, 45(8), 945-948. doi:10.1111/j.1532-5415.1997.tb02964.x | es_ES |
dc.description.references | Suelves, J. M., Martínez, V., & Medina, A. (2010). Lesiones por caídas y factores asociados en personas mayores de Cataluña, España. Revista Panamericana de Salud Pública, 27(1), 37-42. doi:10.1590/s1020-49892010000100006 | es_ES |
dc.description.references | Klarin, I., Wimo, A., & Fastbom, J. (2005). The Association of Inappropriate Drug Use with Hospitalisation and Mortality. Drugs & Aging, 22(1), 69-82. doi:10.2165/00002512-200522010-00005 | es_ES |
dc.description.references | Incalzi, A. R., Capparella, O., Gemma, A., Porcedda, P., Raccis, G., Sommella, L., & Carbonin, P. U. (1992). A Simple Method of Recognizing Geriatric Patients at Risk for Death and Disability. Journal of the American Geriatrics Society, 40(1), 34-38. doi:10.1111/j.1532-5415.1992.tb01826.x | es_ES |
dc.description.references | Campbell, S. E., Seymour, D. G., & Primrose, W. R. (2004). A systematic literature review of factors affecting outcome in older medical patients admitted to hospital. Age and Ageing, 33(2), 110-115. doi:10.1093/ageing/afh036 | es_ES |
dc.description.references | Sotoca Momblona, J. M., Canivell Fusté, S., Alemany Vilches, L., Sisó Almirall, A., Codina Jané, C., & Ribas Sala, J. (2009). Problemas relacionados con la medicación que causan ingresos hospitalarios. Atención Primaria, 41(3), 141-146. doi:10.1016/j.aprim.2008.07.002 | es_ES |
dc.description.references | Martín Martínez, M. A., Alférez, R. C., Escortell Mayor, E., Rico Blázquez, M., & Sarría Santamera, A. (2011). Factores asociados a reingresos hospitalarios en pacientes de edad avanzada. Atención Primaria, 43(3), 117-124. doi:10.1016/j.aprim.2009.12.007 | es_ES |
dc.description.references | Kaur, S., Mitchell, G., Vitetta, L., & Roberts, M. S. (2009). Interventions that can Reduce Inappropriate Prescribing in the Elderly. Drugs & Aging, 26(12), 1013-1028. doi:10.2165/11318890-000000000-00000 | es_ES |
dc.description.references | Shojania, K. G., & Grimshaw, J. M. (2005). Evidence-Based Quality Improvement: The State Of The Science. Health Affairs, 24(1), 138-150. doi:10.1377/hlthaff.24.1.138 | es_ES |
dc.description.references | Mossey, J. M., & Roos, L. L. (1987). Using insurance claims to measure health status: The illness scale. Journal of Chronic Diseases, 40, 41S-50S. doi:10.1016/s0021-9681(87)80031-0 | es_ES |
dc.description.references | Von Korff, M., Wagner, E. H., & Saunders, K. (1992). A chronic disease score from automated pharmacy data. Journal of Clinical Epidemiology, 45(2), 197-203. doi:10.1016/0895-4356(92)90016-g | es_ES |
dc.description.references | Malone, D. C., Billups, S. J., Valuck, R. J., & Carter, B. L. (1999). Development of a Chronic Disease Indicator Score Using a Veterans Affairs Medical Center Medication Database. Journal of Clinical Epidemiology, 52(6), 551-557. doi:10.1016/s0895-4356(99)00029-3 | es_ES |
dc.description.references | Clark, D. O., Korff, M. V., Saunders, K., Balugh, W. M., & Simon, G. E. (1995). A Chronic Disease Score with Empirically Derived Weights. Medical Care, 33(8), 783-795. doi:10.1097/00005650-199508000-00004 | es_ES |
dc.description.references | Lamers, L. M. (1999). Pharmacy Costs Groups. Medical Care, 37(8), 824-830. doi:10.1097/00005650-199908000-00012 | es_ES |
dc.description.references | Lamers, L. M. (2001). Health-Based Risk Adjustment: Is Inpatient and Outpatient Diagnostic Information Sufficient? Inquiry, 38(4), 423-431. doi:10.5034/inquiryjrnl_38.4.423 | es_ES |
dc.description.references | Lamers, L. M., & van Vliet, R. C. J. A. (2004). The Pharmacy-based Cost Group model: validating and adjusting the classification of medications for chronic conditions to the Dutch situation. Health Policy, 68(1), 113-121. doi:10.1016/j.healthpol.2003.09.001 | es_ES |
dc.description.references | Lamers, L. M., & Vliet, R. C. J. A. (2003). Health-based risk adjustment Improving the pharmacy-based cost group. The European Journal of Health Economics, 4(2), 107-114. doi:10.1007/s10198-002-0159-9 | es_ES |
dc.description.references | Johnson, R. E., Hornbrook, M. C., & Nichols, G. A. (1994). Replicating the chronic disease score (CDS) from automated pharmacy data. Journal of Clinical Epidemiology, 47(10), 1191-1199. doi:10.1016/0895-4356(94)90106-6 | es_ES |
dc.description.references | Stam, P. J. A., van Vliet, R. C. J. A., & van de Ven, W. P. M. M. (2010). Diagnostic, Pharmacy-Based, and Self-Reported Health Measures in Risk Equalization Models. Medical Care, 48(5), 448-457. doi:10.1097/mlr.0b013e3181d559b4 | es_ES |
dc.description.references | Weiner, J. P., Starfield, B. H., Steinwachs, D. M., & Mumford, L. M. (1991). Development and Application of a Population-Oriented Measure of Ambulatory Care Case-Mix. Medical Care, 29(5), 452-472. doi:10.1097/00005650-199105000-00006 | es_ES |
dc.description.references | Hughes, J. S., Averill, R. F., Eisenhandler, J., Goldfield, N. I., Muldoon, J., Neff, J. M., & Gay, J. C. (2004). Clinical Risk Groups (CRGs). Medical Care, 42(1), 81-90. doi:10.1097/01.mlr.0000102367.93252.70 | es_ES |
dc.description.references | García-Goñi, M., & Ibern, P. (2007). Predictability of drug expenditures: an application using morbidity data. Health Economics, 17(1), 119-126. doi:10.1002/hec.1238 | es_ES |
dc.description.references | García-Goñi, M., Ibern, P., & Inoriza, J. M. (2008). Hybrid risk adjustment for pharmaceutical benefits. The European Journal of Health Economics, 10(3), 299-308. doi:10.1007/s10198-008-0133-2 | es_ES |
dc.description.references | Hanley, G. E., Morgan, S., & Reid, R. J. (2010). Explaining Prescription Drug Use and Expenditures Using the Adjusted Clinical Groups Case-Mix System in the Population of British Columbia, Canada. Medical Care, 48(5), 402-408. doi:10.1097/mlr.0b013e3181ca3d5d | es_ES |
dc.description.references | Buchner, F., Goepffarth, D., & Wasem, J. (2013). The new risk adjustment formula in Germany: Implementation and first experiences. Health Policy, 109(3), 253-262. doi:10.1016/j.healthpol.2012.12.001 | es_ES |
dc.description.references | Vivas-Consuelo, D., Usó-Talamantes, R., Guadalajara-Olmeda, N., Trillo-Mata, J.-L., Sancho-Mestre, C., & Buigues-Pastor, L. (2014). Pharmaceutical cost management in an ambulatory setting using a risk adjustment tool. BMC Health Services Research, 14(1). doi:10.1186/1472-6963-14-462 | es_ES |
dc.description.references | Lane, C. J., Bronskill, S. E., Sykora, K., Dhalla, I. A., Anderson, G. M., Mamdani, M. M., … Rochon, P. A. (2004). Potentially Inappropriate Prescribing in Ontario Community-Dwelling Older Adults and Nursing Home Residents. Journal of the American Geriatrics Society, 52(6), 861-866. doi:10.1111/j.1532-5415.2004.52250.x | es_ES |
dc.description.references | King, M. A., & Roberts, M. S. (2007). The influence of the Pharmaceutical Benefits Scheme (PBS) on inappropriate prescribing in Australian nursing homes. Pharmacy World & Science, 29(1), 39-42. doi:10.1007/s11096-005-5618-9 | es_ES |
dc.description.references | Bradley, M. C., Motterlini, N., Padmanabhan, S., Cahir, C., Williams, T., Fahey, T., & Hughes, C. M. (2014). Potentially inappropriate prescribing among older people in the United Kingdom. BMC Geriatrics, 14(1). doi:10.1186/1471-2318-14-72 | es_ES |
dc.description.references | Dalleur, O., Boland, B., Losseau, C., Henrard, S., Wouters, D., Speybroeck, N., … Spinewine, A. (2014). Reduction of Potentially Inappropriate Medications Using the STOPP Criteria in Frail Older Inpatients: A Randomised Controlled Study. Drugs & Aging, 31(4), 291-298. doi:10.1007/s40266-014-0157-5 | es_ES |
dc.description.references | Wessell, A. M., Nietert, P. J., Jenkins, R. G., Nemeth, L. S., & Ornstein, S. M. (2008). Inappropriate medication use in the elderly: Results from a quality improvement project in 99 primary care practices. The American Journal of Geriatric Pharmacotherapy, 6(1), 21-27. doi:10.1016/j.amjopharm.2008.02.001 | es_ES |
dc.description.references | Beers, M. H. (1991). Explicit Criteria for Determining Inappropriate Medication Use in Nursing Home Residents. Archives of Internal Medicine, 151(9), 1825. doi:10.1001/archinte.1991.00400090107019 | es_ES |
dc.description.references | Knight, E. L. (2001). Quality Indicators for Appropriate Medication Use in Vulnerable Elders. Annals of Internal Medicine, 135(8_Part_2), 703. doi:10.7326/0003-4819-135-8_part_2-200110161-00009 | es_ES |
dc.description.references | Fick, D. M., Cooper, J. W., Wade, W. E., Waller, J. L., Maclean, J. R., & Beers, M. H. (2003). Updating the Beers Criteria for Potentially Inappropriate Medication Use in Older Adults. Archives of Internal Medicine, 163(22), 2716. doi:10.1001/archinte.163.22.2716 | es_ES |
dc.description.references | Gallagher, P., Ryan, C., Byrne, S., Kennedy, J., & O Mahony, D. (2008). STOPP (Screening Tool of Older Person s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int. Journal of Clinical Pharmacology and Therapeutics, 46(02), 72-83. doi:10.5414/cpp46072 | es_ES |
dc.description.references | Delgado Silveira, E., Muñoz García, M., Montero Errasquin, B., Sánchez Castellano, C., Gallagher, P. F., & Cruz-Jentoft, A. J. (2009). Prescripción inapropiada de medicamentos en los pacientes mayores: los criterios STOPP/START. Revista Española de Geriatría y Gerontología, 44(5), 273-279. doi:10.1016/j.regg.2009.03.017 | es_ES |
dc.description.references | Barry, P. J., Gallagher, P., Ryan, C., & O’mahony, D. (2007). START (screening tool to alert doctors to the right treatment) an evidence-based screening tool to detect prescribing omissions in elderly patients. Age and Ageing, 36(6), 632-638. doi:10.1093/ageing/afm118 | es_ES |
dc.description.references | Wenger, N. S. (2001). Assessing Care of Vulnerable Elders: ACOVE Project Overview. Annals of Internal Medicine, 135(8_Part_2), 642. doi:10.7326/0003-4819-135-8_part_2-200110161-00002 | es_ES |
dc.description.references | Fick, D. M., Mion, L. C., Beers, M. H., & L. Waller, J. (2008). Health outcomes associated with potentially inappropriate medication use in older adults. Research in Nursing & Health, 31(1), 42-51. doi:10.1002/nur.20232 | es_ES |
dc.description.references | Clyne, B., Bradley, M. C., Hughes, C., Fahey, T., & Lapane, K. L. (2012). Electronic Prescribing and Other Forms of Technology to Reduce Inappropriate Medication Use and Polypharmacy in Older People: A Review of Current Evidence. Clinics in Geriatric Medicine, 28(2), 301-322. doi:10.1016/j.cger.2012.01.009 | es_ES |
dc.description.references | Curtain, C., & Peterson, G. M. (2014). Review of computerized clinical decision support in community pharmacy. Journal of Clinical Pharmacy and Therapeutics, 39(4), 343-348. doi:10.1111/jcpt.12168 | es_ES |
dc.description.references | Raebel, M. A., Charles, J., Dugan, J., Carroll, N. M., Korner, E. J., Brand, D. W., & Magid, D. J. (2007). Randomized Trial to Improve Prescribing Safety in Ambulatory Elderly Patients. Journal of the American Geriatrics Society, 55(7), 977-985. doi:10.1111/j.1532-5415.2007.01202.x | es_ES |
dc.description.references | Crotty, M., Rowett, D., Spurling, L., Giles, L. C., & Phillips, P. A. (2004). Does the addition of a pharmacist transition coordinator improve evidence-based medication management and health outcomes in older adults moving from the hospital to a long-term care facility? Results of a randomized, controlled trial. The American Journal of Geriatric Pharmacotherapy, 2(4), 257-264. doi:10.1016/j.amjopharm.2005.01.001 | es_ES |
dc.description.references | Clyne, B., Bradley, M. C., Smith, S. M., Hughes, C. M., Motterlini, N., … Clear, D. (2013). Effectiveness of medicines review with web-based pharmaceutical treatment algorithms in reducing potentially inappropriate prescribing in older people in primary care: a cluster randomized trial (OPTI-SCRIPT study protocol). Trials, 14(1), 72. doi:10.1186/1745-6215-14-72 | es_ES |
dc.description.references | Hanlon, J. T., Weinberger, M., Samsa, G. P., Schmader, K. E., Uttech, K. M., Lewis, I. K., … Feussner, J. R. (1996). A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. The American Journal of Medicine, 100(4), 428-437. doi:10.1016/s0002-9343(97)89519-8 | es_ES |
dc.description.references | Krska, J. (2001). Pharmacist-led medication review in patients over 65: a randomized, controlled trial in primary care. Age and Ageing, 30(3), 205-211. doi:10.1093/ageing/30.3.205 | es_ES |
dc.description.references | Saltvedt, I., Spigset, O., Ruths, S., Fayers, P., Kaasa, S., & Sletvold, O. (2005). Patterns of drug prescription in a geriatric evaluation and management unit as compared with the general medical wards: a randomised study. European Journal of Clinical Pharmacology, 61(12), 921-928. doi:10.1007/s00228-005-0046-2 | es_ES |
dc.description.references | Meredith, S., Feldman, P., Frey, D., Giammarco, L., Hall, K., Arnold, K., … Ray, W. A. (2002). Improving Medication Use in Newly Admitted Home Healthcare Patients: A Randomized Controlled Trial. Journal of the American Geriatrics Society, 50(9), 1484-1491. doi:10.1046/j.1532-5415.2002.50402.x | es_ES |
dc.description.references | Kim, J., Ahn, B.-J., Chae, H.-S., Han, S., Doh, K., Choi, J., … Yim, D.-S. (2011). A Population Pharmacokinetic-Pharmacodynamic Model for Simvastatin that Predicts Low-Density Lipoprotein-Cholesterol Reduction in Patients with Primary Hyperlipidaemia. Basic & Clinical Pharmacology & Toxicology, 109(3), 156-163. doi:10.1111/j.1742-7843.2011.00700.x | es_ES |
dc.description.references | Reeve, E., Shakib, S., Hendrix, I., Roberts, M. S., & Wiese, M. D. (2014). Review of deprescribing processes and development of an evidence-based, patient-centred deprescribing process. British Journal of Clinical Pharmacology, 78(4), 738-747. doi:10.1111/bcp.12386 | es_ES |
dc.description.references | Zermansky, A. G., Alldred, D. P., Petty, D. R., Raynor, D. K., Freemantle, N., Eastaugh, J., & Bowie, P. (2006). Clinical medication review by a pharmacist of elderly people living in care homes—randomised controlled trial. Age and Ageing, 35(6), 586-591. doi:10.1093/ageing/afl075 | es_ES |
dc.description.references | Salisbury, C. (2013). Multimorbidity: time for action rather than words. British Journal of General Practice, 63(607), 64-65. doi:10.3399/bjgp13x661020 | es_ES |
dc.description.references | Roland, M., & Paddison, C. (2013). Better management of patients with multimorbidity. BMJ, 346(may02 1), f2510-f2510. doi:10.1136/bmj.f2510 | es_ES |
dc.description.references | Ammenwerth, E., Duftschmid, G., Gall, W., Hackl, W. O., Hoerbst, A., Janzek-Hawlat, S., … Dorda, W. (2014). A nationwide computerized patient medication history: Evaluation of the Austrian pilot project «e-Medikation». International Journal of Medical Informatics, 83(9), 655-669. doi:10.1016/j.ijmedinf.2014.06.004 | es_ES |